News

Melissa Amrein, at the University Hospital of Basel, Switzerland is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France

Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform

World Diabetes Day – Recent discovery of proteins is significant in diabetic kidney disease research

Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies

Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform

Our new website is now live!

Interview with Charlotte Teunissen on VJN

CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services

UK Biobank project extended to Explore 3072

Announcing Olink Explore 3072